INTRODUCTION
Tuberculosis is a major health burden worldwide. The national treatment regimens for TB patients recommend the use of the five first lines anti TB drugs Isoniazid (INH), rifampicin (R), ethambutol (E), pyrazinamide (P) and streptomycin (S).
1 High hepatotoxic potential first-line antitubercular drugs are INH, R and P sometimes may need discontinuation. Tuberculosis is being increasingly recognized as a cause of acute respiratory distress syndrome.
2
Maintaining oxygenation are very much challenging in a patient of tuberculosis associated with ARDS. Many times we need muscle relaxation with adequate sedation for maintaining oxygen saturation and lung recruitment. The selection of muscle relaxant in patients taking antitubercular treatment (ATT) with deranged liver function is challenging as it not only decreases metabolism of muscle relaxant but also potentiates its action due to the accumulation of metabolites. Skeletal muscle weakness has a confusing list of names and syndromes, including Acute Quadriplegic Myopathy Syndrome (AQMS), floppy man syndrome, Critical Illness Polyneuropathy (CIP) and acute myopathy of intensive care, etc.
3

CASE PRESENTATION
We report a diagnosed case of miliary tuberculosis (Figure 1 ) of a 16 years-old normotensive, non-diabetic female patient on HRZE regimen who developed severe ARDS. At the time of admission to Intensive Care Unit (ICU), she was conscious, oriented, febrile, cyanosed, tachypneic with a respiratory rate of 38/min, pulse rate of 104 beats/min, temperature of 101.8ºF, blood pressure of 138/78 mmHg, and oxygen saturation of 78% on 15 litres per minute of oxygen by facemask. Systemic examination revealed bilateral coarse crepitations in the lungs. Rest of the examination was unremarkable.
Initial investigations revealed hemoglobine 9 g/dl and leucocyte count 23 x10 The patient was managed with invasive mechanical ventilation and broad-spectrum antibiotics and steroids. Influenza retroviral and other virological serologies were negative. Blood and urine culture came sterile. There was no evidence of fungal infection. Bedside echo result was normal.
Tracheal aspiration showed strong positivity for Mycobacterium tuberculosis but Mantoux test came negative. Later on we found increased peak 
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DISCUSSION
As per our knowledge, this is the first case reported in miliary tuberculosis patient on ATT developing ARDS on receiving vecuronium infusion developed quadriparesis. Careful considerations must be held before using muscle relaxant especially in ARDS patients with disseminated miliary tuberculosis receiving anti-tubercular drugs with deranged liver function, as it not only decreases metabolism and but the action of vecuronium was potentiated by streptomycin and corticosteroid which may result in the development of CIPM. Oxygenation of the lung can be improved by reducing oxygen consumption 4 and by providing homogenous distribution of positive-end expiratory pressure (PEEP) and tidal volume which prevents barotrauma and worsening of ARDS.
Forel et al 5 demonstrated neuromuscular blocking agents (NMBAs) may decrease the inflammatory response associated with ARDS. NMBAs may cause harmful effects, particularly Critical Illness Polyneuro Myopathy (CIPM) when used for prolonged periods or in septic shock. In our case we did not perform electromyography (EMG) and nerve conduction velocity (NCV) tests because of their unavailability at our institute, but neurological examination reveals a global motor deficit affecting muscles in both the upper and lower extremities and decreased motor reflexes with preserved sensory reflexes and extraocular muscle function, so we probably diagnose our case as CIPM. 
